|
|
|
|
Nano
Biz...in depth...
im detail
|
|
NanoBioMagnetics
Announces Strategic Partnership with Sono-Tek
|
|
MILTON,
N.Y., Sept. 21 /PRNewswire-FirstCall/ -- Sono-Tek
Corporation (OTB Bulletin Board: SOTK) the world's
leader in ultrasonic spray nozzle technology, have
announced that its strategic partner in the field
of nanotechnology, NanoBioMagnetics, has formed a
new subsidiary to be called ZetaCor, LLC. The new,
wholly-owned subsidiary will produce specialized nanoparticles
for research and commercial applications.
At the center of ZetaCor's formation is a strategic
partnership between NBMI and Sono-Tek of Milton, NY.
Early in 2004, NBMI purchased from Sono-Tek one of
the first SonoDry ultrasonic spray nozzle systems
and is incorporating it into a full lab scale spray
drying system.
"NBMI provides us with a resource that has extensive
expertise in the nanoparticle industry that we have
not had to date," says Dr. Chris Coccio, president
and CEO of Sono-Tek Corporation. "We believe
our partnership with NBMI will shorten Sono-Tek's
learning curve for entering products into the nano
industry, while providing NBMI unique access to a
hardware manufacturer that is willing to customize
machinery for their needs."
"This partnership represents a marriage of technologies,"
says Charles Seeney, president and CEO of NBMI. "By
combining the technologies developed by Sono-Tek and
NBMI, will be able to further refine the nanofabrication
of unique powders and composites across a wide range
of variables."
Seeney points out that the companies, individuals
and institutions researching this multifaceted field
have very specific requirements for their nanomaterials.
NBMI currently produces magnetically responsive nanoparticles
for human health applications. NBMI has moved to validation
and prototype development of an organ-assisting-device
(OAD) technology for hearing amplification. NBMI also
is developing OAD technologies for site-specific delivery
of therapeutics, currently an area of intense research
interest, especially with chemotherapeutics.
"Nanotechnology research has come to the point
where off-the-shelf nanomaterials are no longer sufficient,"
says Seeney. "There is a growing market for new,
custom nanomaterials created within very narrow parameters
for specialized applications. This is our forte. We
have the experience and the technology to develop
unique nanomaterials capable of meeting exacting standards."
For the time being, ZetaCor will share NMBI's Edmond,
Oklahoma offices. However, if growth is as rapid as
anticipated, ZetaCor will have its own facilities
in the near future. "
This press release contains forward looking statements
regarding future events and the future performance
of Sono-Tek Corporation that involve risks and uncertainties
that could cause actual results to differ materially.
These factors include, among other considerations,
general economic and business conditions; political,
regulatory, competitive and technological developments
affecting the Company's operations or the demand for
its products; timely development and market acceptance
of new products; adequacy of financing; capacity additions
and the ability to enforce patents. We refer you to
documents that the company files with the Securities
and Exchange Commission, which include Form 10-KSB
and Form 10-QSB containing additional important information.
Source: Sono-Tek Corporation
CONTACT: Christopher L. Coccio, CEO and President,
+1-845-795-2020,
coccio@sono-tek.com
Web site: http://www.sono-tek.com/
|
www.nano-tsunami.com
This
story has been adapted from a news release -
Diese Meldung basiert auf einer Pressemitteilung
-
Deze
tekst is gebaseerd op een nieuwsbericht -
|
|
|

Nano Biz
|
|